Synthetic Nano-Chaperone Folds, Stabilizes, and Delivers Cancer-Fighting Peptides into Cells | Research

The takeaway

A bio-inspired porous nanoparticle system simultaneously folds, stabilizes, and delivers therapeutic α-helical peptides into cancer cells, effectively inhibiting tumor growth in vivo.

Triple function: fold + stabilize + deliver
The SNCP nanoparticle simultaneously folds peptides into their active shape, stabilizes them against degradation, and delivers them into cancer cells — solving three major peptide drug challenges at once

What the researchers found

The synthetic nano-chaperone improved cellular uptake and bioavailability of peptides, effectively inhibiting cancer growth.

Why it matters

This research could lead to more effective peptide therapies for cancer by addressing the challenges of peptide stability and delivery.

How the study worked

The study involved creating porous nanoparticles that stabilize α-helical peptides and testing their delivery and efficacy in cancer cells.

What this study cannot tell us

The study primarily focuses on in vitro and in vivo models, which may not fully predict human responses.

How to read the evidence

Published in Nature Communications, this is a well-characterized preclinical study with both in vitro and in vivo data demonstrating efficacy. The technology is rigorously validated at the proof-of-concept level, though clinical translation remains to be established.

When this study was published

Published in 2022 in Nature Communications, this study represents a significant advance in peptide delivery technology that continues to be relevant as peptide therapeutics become increasingly important in drug development.

The bigger picture

Peptide therapeutics are one of the fastest-growing drug classes, but their clinical potential has been limited by instability, poor cellular uptake, and rapid degradation. This nano-chaperone technology addresses all these limitations in a single platform. By combining folding, stabilization, and delivery, it could dramatically expand the range of peptides that can be developed as drugs. The approach is particularly powerful for α-helical peptides — a class that includes many promising cancer therapeutics that have failed to reach clinical use due to delivery challenges.

Questions still open

Can the SNCP platform be adapted for peptide drug classes beyond α-helical structures?
What is the biodistribution and clearance profile of the porous nanoparticles in healthy tissue?
Could this technology enable oral delivery of peptide drugs that currently require injection?

Common questions

What is a nano-chaperone and how does it help peptide drugs?

In biology, chaperone proteins help other proteins fold into their correct shape. This synthetic nano-chaperone mimics that function using porous nanoparticles. Therapeutic peptides are loaded into the pores, where the hydrophobic environment helps them fold into their active α-helical shape. The nanoparticle then protects the peptide from degradation and delivers it into cancer cells — solving the three biggest problems that have prevented many promising peptides from becoming effective drugs.

Why is peptide folding important for cancer therapy?

Many cancer-fighting peptides need to be in a specific 3D shape (α-helix) to interact with their targets inside cancer cells. Outside the body, these peptides tend to unfold and lose their activity. By keeping the peptides properly folded inside porous nanoparticles, the nano-chaperone ensures they arrive at their target in their active, cancer-killing form.

Read the original research

Multifunctional synthetic nano-chaperone for peptide folding and intracellular delivery.

Nature communications, 13(1), 4568

View on PubMed ↗Publisher’s paper ↗

Citation

Park, Il-Soo; Kim, Seongchan; Yim, Yeajee; Park, Ginam; Choi, Jinahn; Won, Cheolhee; Min, Dal-Hee. (2022). Multifunctional synthetic nano-chaperone for peptide folding and intracellular delivery.. Nature communications, 13(1), 4568. https://doi.org/10.1038/s41467-022-32268-2